Analysts at Pivotal Research initiated coverage on USANA Health Sciences USNA with a Buy rating.
The target price for USANA Health Sciences is set to $100.
USANA Health Sciences shares have dropped 7.92% over the past 52 weeks, while the S&P 500 index has surged 8.14% in the same period.
USANA Health Sciences' shares surged 0.40% to close at $80.36 on Friday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in